Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Cancer Lett. 2004 Aug 30;212(2):177-84.

Theanine, a specific glutamate derivative in green tea, reduces the adverse reactions of doxorubicin by changing the glutathione level.

Author information

  • 1Department of Food Science Research for Health, National Institute of Health and Nutrition, 1-23-1 Toyama, Shinjuku-ku, Tokyo 162-8636, Japan.

Abstract

We previously showed that theanine, a specific glutamate derivative in green tea, decreased doxorubicin (DOX)-induced adverse reactions such as the induction of the lipid peroxide level and the reduction of glutathione peroxidase activity in normal tissues. In order to clarify how theanine attenuates the adverse reactions of DOX, we have focused on the effects of theanine on glutamate and glutathione (GSH) levels in normal tissues. The administration of theanine to mice increased the glutamate concentration in the liver and heart, and not in tumors. In vitro examinations indicated that theanine was metabolized to glutamate mainly in the liver. Moreover, theanine inhibited GSH reduction induced by DOX in the liver and heart. Therefore, these results suggested that theanine attenuated the DOX-induced adverse reactions involved in oxidative damage, due to increase in glutamate and the recovery of GSH levels in normal tissues.

PMID:
15279898
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk